Literature DB >> 1433175

Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase.

M J Lee1, H T Nagasawa, J A Elberling, E G DeMaster.   

Abstract

In the preceding paper, analogs of chlorpropamide with an OMe substituent on the sulfonamide nitrogen were shown to inhibit aldehyde dehydrogenase (AlDH), and it was postulated that these compounds were bioactivated by O-demethylation to release nitroxyl (HN = O, nitrosyl hydride), which is an inhibitor of AlDH. Further evidence for the production of nitroxyl from compounds with O-acyl instead of OMe on the sulfonamide nitrogen is now presented. Thus, nitrous oxide (N2O), the end product of nitroxyl dimerization and disproportionation, was found to be generated on alkaline or enzymatic hydrolysis of N,O-diacylated N-hydroxyarylsulfonamides. Since the latter compounds strongly inhibit yeast AlDH in vitro after bioactivation by an esterase intrinsic to this enzyme, nitroxyl generated from these compounds must be the common intermediate that inhibits AlDH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433175     DOI: 10.1021/jm00098a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase.

Authors:  Ryan J Holland; Rika Paulisch; Zhao Cao; Larry K Keefer; Joseph E Saavedra; Sonia Donzelli
Journal:  Nitric Oxide       Date:  2013-10-11       Impact factor: 4.427

Review 2.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

Review 3.  The chemical biology of HNO signaling.

Authors:  Christopher L Bianco; John P Toscano; Michael D Bartberger; Jon M Fukuto
Journal:  Arch Biochem Biophys       Date:  2016-08-20       Impact factor: 4.013

Review 4.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

5.  Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects.

Authors:  Murugaeson R Kumar; Jon M Fukuto; Katrina M Miranda; Patrick J Farmer
Journal:  Inorg Chem       Date:  2010-07-19       Impact factor: 5.165

6.  Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class.

Authors:  Daniela Andrei; Debra J Salmon; Sonia Donzelli; Azadeh Wahab; John R Klose; Michael L Citro; Joseph E Saavedra; David A Wink; Katrina M Miranda; Larry K Keefer
Journal:  J Am Chem Soc       Date:  2010-10-29       Impact factor: 15.419

7.  Synthesis and characterization of lithium oxonitrate (LiNO).

Authors:  Christopher H Switzer; Thomas W Miller; Patrick J Farmer; Jon M Fukuto
Journal:  J Inorg Biochem       Date:  2012-10-06       Impact factor: 4.155

8.  Xerogel optical sensor films for quantitative detection of nitroxyl.

Authors:  Kevin P Dobmeier; Daniel A Riccio; Mark H Schoenfisch
Journal:  Anal Chem       Date:  2008-01-16       Impact factor: 6.986

9.  Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method.

Authors:  Michael D Hoffman; Geraldine M Walsh; Jason C Rogalski; Juergen Kast
Journal:  Mol Cell Proteomics       Date:  2008-12-31       Impact factor: 5.911

Review 10.  Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.

Authors:  Mai E Shoman; Omar M Aly
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.